The Australian market traded in green zone on December 13, 2019 and S&P/ASX 200 closed at 6739.7 with a rise of 30.9 points or 0.5% on an intraday basis. Let us now have a look at the performance of some sectors. On December 13, 2019, S&P/ASX 200 Financials (Sector) closed at 6,029.7, reflecting a rise of 1.38% on an intraday basis. In addition, S&P/ASX 200 Information Technology (Sector) ended the session with a rise of 21.3 points on an intraday basis and settled at 1,418.9. On the end of same trading day, All Ordinaries stood at 6844.6 with an increase of 0.5%.
At the close of trading session, some companies closed the session with a decent rise on an intraday basis. PolyNovo Limited (ASX: PNV) ended the session at A$1.940 per share, going up by 11.816% on an intraday basis. The another performer on Australian Stock Exchange (or ASX) was Galaxy Resources Limited (ASX: GXY), which rose by 9.884% and closed at A$0.945 per share.
With respect to NZX Main Board, let us now get to know about the top gainers and losers during the trading session. Good Spirits Hospitality Limited (NZX: GSH) stood at NZ$0.139 per share at the close of trading session and AMP Limited (NZX: AMP) ended the session at a closing price of NZ$2.020 with a rise of 3.59%. Talking about the losers, Z Energy Limited witnessed a fall of 12.78% and stood at NZ$4.230. Allied Farmers Limited (NZX: ALF) stood at NZ$0.640 per share, reflecting a decline of 5.88% on an intraday basis.
We had written some crucial information on CV Check Ltd (ASX: CV1) and advise the market participants to go through the content written. To read the information, please click here.
PolyNovo Limited Rose 11.816% on Australian Stock Exchange
PolyNovo Limited (ASX: PNV), on December 13, 2019, announced that NovoSorb BTM has been granted a certificate of conformance (CE Mark) approval with respect to the sale across the UK/Ireland as well as the European Union. Notably, NovoSorb BTM has been approved for the use in all full dermal loss procedures like full thickness burns, trauma, reconstructive / wide excision surgery, revision of scar, venous leg Ulcers, diabetic foot ulcers, pressure injuries and any loss of dermis needing repair.
As per the key personnel of the company, there are expectations that PNV would have early sales in the UK/Ireland and in Germany through PMI. The company would now quickly expand its direct sales force in other parts of the EU.
Pendal Group Limited’s Key Personnel Addresses Shareholders
Pendal Group Limited (ASX: PDL), on December 13, 2019, addressed the shareholders, highlighting that cash net profit after tax, a key measure of financial performance, stood at $163.5 million in FY 2019, reflecting a fall of 19%. The company declared final dividend amounting to 25cps, bringing the total dividend for FY19 to 45 cents per share.GSH Daily Technical Chart (Source: Thomson Reuters)
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.